Global Cardiovascular System Market Research Report
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
Non-selective calcium channel blockers Non-selective calcium channel blockers and its peer markets - Selective calcium channel blockers with mainly vascular... |
Upcoming |
|
|
Calcium channel blockers and diuretics Calcium channel blockers and diuretics and its peer markets - Selective calcium channel blockers with direct cardiac... |
Upcoming |
|
|
Ace inhibitors, plain Ace inhibitors, plain and its peer markets - Immunoassay, Ace... |
Upcoming |
|
|
Ace inhibitors, combinations Ace inhibitors, combinations and its peer markets - Ace inhibitors, plain, |
Upcoming |
|
|
Angiotensin II antagonists, plain Angiotensin II antagonists, plain and its peer markets - Ace inhibitors, plain, |
Upcoming |
|
|
Angiotensin II antagonists, combinations Angiotensin II antagonists, combinations and its peer markets - Healthcare IT outsourcing, |
Upcoming |
|
|
Lipid modifying agents, plain Lipid modifying agents, plain and its peer markets - Wireless Health, |
Upcoming |
|
|
Lipid modifying agents, combinations Lipid modifying agents, combinations and its peer markets - Chromatography, |
Upcoming |
|
|
Peripheral vasodilator enzymes Peripheral vasodilator enzymes and its peer markets - E-Clinical Trial Solutions, |
Upcoming |
|
|
Agents for treatment of hemorrhoids and anal fissures for topical use Agents for treatment of hemorrhoids and anal fissures for topical use and its peer markets - Immunoassay, |
Upcoming |
|
|
Digitalis glycosides Digitalis glycosides and its peer markets - Clinical Trial Management Systems (CTMS), |
Upcoming |
|
|
Scilla glycosides Scilla glycosides and its peer markets - Next Generation Sequencing (NGS), |
Upcoming |
|
|
Strophantus glycosides Strophantus glycosides and its peer markets - E-Clinical Trial Solutions, |
Upcoming |
|
|
Antiarrhythmics, class Ia Antiarrhythmics, class Ia and its peer markets - Antiarrhythmics, class III, |
Upcoming |
|
|
Antiarrhythmics, class Ib Antiarrhythmics, class Ib and its peer markets - Other class I antiarrhythmics, |
Upcoming |
|
|
Antiarrhythmics, class Ic Antiarrhythmics, class Ic and its peer markets - Antiarrhythmics, class Ib, |
Upcoming |
|
|
Antiarrhythmics, class III Antiarrhythmics, class III and its peer markets - Antiarrhythmics, class Ib, |
Upcoming |
|
|
Adrenergic and dopaminergic agents Adrenergic and dopaminergic agents and its peer markets - Wireless Health, |
Upcoming |
|
|
Phosphodiesterase inhibitors Phosphodiesterase inhibitors and its peer markets - Clinical Trial Management Systems (CTMS), |
Upcoming |
|
|
Organic nitrates Organic nitrates and its peer markets - Clinical Trial Management Systems (CTMS), |
Upcoming |
ATC
